Literature DB >> 2926171

Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii.

Y Suzuki1, F K Conley, J S Remington.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2926171     DOI: 10.1093/infdis/159.4.790

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Comparison of isoenzyme profiles of Toxoplasma gondii tachyzoites produced under different culture conditions.

Authors:  M L Dardé; B Bouteille; M Pestre-Alexandre
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

2.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Genetic characteristics of the Korean isolate KI-1 of Toxoplasma gondii.

Authors:  Aifen Lin; Eun-Hee Shin; Tae-Yun Kim; Jae-Hwan Park; Sang-Mee Guk; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2005-03       Impact factor: 1.341

4.  Experimental ocular toxoplasmosis in genetically susceptible and resistant mice.

Authors:  Fangli Lu; Shiguang Huang; Mark S Hu; Lloyd H Kasper
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii.

Authors:  D J Ferguson; J Huskinson-Mark; F G Araujo; J S Remington
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

6.  A morphological study of chronic cerebral toxoplasmosis in mice: comparison of four different strains of Toxoplasma gondii.

Authors:  D J Ferguson; J Huskinson-Mark; F G Araujo; J S Remington
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

7.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

8.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

9.  In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.

Authors:  F G Araujo; R M Shepard; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

10.  Differentiation between mouse-virulent and -avirulent strains of Toxoplasma gondii by a monoclonal antibody recognizing a 27-kilodalton antigen.

Authors:  W Bohne; U Gross; J Heesemann
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.